Introduction

The Journal of Commercial Biotechnology is an international peer-reviewed, professional journal which focuses on the commercial, legal and regulatory issues affecting biotech, biopharmaceutical, agrochemical and environmental companies.

News

Journal of Commercial Biotechnology Editor Awarded Prestigious Kyoto Prize Journalism Fellowship

Palgrave Macmillan, the academic publishing division of Macmillan Publishers Ltd is pleased to announce that Dr Yali Friedman, Managing Editor of the Journal of Commercial Biotechnology has been awarded the Kyoto Prize Journalism Fellowship by the Point Loma Nazarene University (San Diego, California).

View Press Release

Advance Online Publication (AOP)

Journal of Commercial Biotechnology is now utilising our industry leading Advance Online Publication (AOP) service. This service enables us to publish online the final version of a paper, fully citeable and exactly as it will be published in the printed edition. In some instances papers are published AOP a significant number of months before appearing in print.
View Advance Online Publication.

Event

Seminar: Bridging the Innovation Gap in the Development of Breakthrough Medicines, 5th November, Abu Dhabi

The world faces an unacceptable burden of neglected diseases (including cryptosporidiosis, dengue, schistosomiasis, leishmaniasis and leprosy) and therapies move slowly, if at all, from discovery to the patient. This seminar, hosted by the Health Authority - Abu Dhabi, will focus on the challenge of the "innovation gap" between discovery and proof-of-concept for breakthrough therapies against neglected infectious diseases.

View seminar details [PDF, 225KB]